# Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

> **NCT02710370** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Pittsburgh** · enrollment: 46 (actual)

## Conditions studied

- Obesity
- Diabetes Mellitus, Type 2
- Endocrine System Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02710370
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-02
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02710370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02710370, "Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02710370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*